Furthermore, CYP26A1 overexpression was significantly associated with the primary tumor stage of carcinomas and pTNM stage (Table 2), suggesting that CYP26A1 was primarily correlated with primary tumor growth in HNC patients. Here, CYP26A1 is linked to neoplasm.